Molecule Details
| InChIKey | HAUGBCQQUOZSGH-UHFFFAOYSA-N |
|---|---|
| Compound Name | 2,6-Dichloro-N-(difluoromethyl)-4-(2-(piperazin-1-yl)pyridin-4-yl)-N-(1,3,5-trimethyl-1H-pyrazol-4-yl)benzenesulfonamide |
| Canonical SMILES | Cc1nn(C)c(C)c1N(C(F)F)S(=O)(=O)c1c(Cl)cc(-c2ccnc(N3CCNCC3)c2)cc1Cl |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 3 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 8.01 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile
Target Activities (3)
| Target | Gene | Organism | Category | Pfam | pChEMBL | Type | Source |
|---|---|---|---|---|---|---|---|
| P30419 | NMT1 | Homo sapiens | Human | PF01233 PF02799 | 7.7 | IC50 | ChEMBL;BindingDB |
| Q4Q5S8 | NMT | Leishmania major | Pathogen | PF01233 PF02799 | 8.3 | IC50 | ChEMBL;BindingDB |
| Q388H8 | Trypanosoma brucei brucei (strain 927/4 GUTat10.1) | Pathogen | PF01233 PF02799 | 8.0 | IC50 | ChEMBL;BindingDB |